Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.

per Frey, K A, Hichwa, R D, Ehrenkaufer, R L, Agranoff, B W
Publicat 1985

Striatal [(11)C]dihydrotetrabenazine and [(11)C]methylphenidate binding in Tourette syndrome

per Albin, R L., Koeppe, R A., Wernette, K, Zhuang, W, Nichols, T, Kilbourn, M R., Frey, K A.
Publicat 2009

Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease

per Ridder, A., Müller, M.L.T.M., Kotagal, V., Frey, K.A., Albin, R.L., Bohnen, N.I.
Publicat a Parkinsonism Relat Disord (2016)

History of falls in Parkinson disease is associated with reduced cholinergic activity

per Bohnen, N I., Müller, M L.T.M., Koeppe, R A., Studenski, S A., Kilbourn, M A., Frey, K A., Albin, R L.
Publicat 2009

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

per Ludolph, A. C., Kassubek, J., Landwehrmeyer, B. G., Mandelkow, E., Mandelkow, E.-M., Burn, D. J., Caparros-Lefebvre, D., Frey, K. A., de Yebenes, J. G., Gasser, T., Heutink, P., Höglinger, G., Jamrozik, Z., Jellinger, K. A., Kazantsev, A., Kretzschmar, H., Lang, A. E., Litvan, I., Lucas, J. J., McGeer, P. L., Melquist, S., Oertel, W., Otto, M., Paviour, D., Reum, T., Saint-Raymond, A., Steele, J. C., Tolnay, M., Tumani, H., van Swieten, J. C., Vanier, M. T., Vonsattel, J.-P., Wagner, S., Wszolek, Z. K.
Publicat 2009